Results 31 to 40 of about 8,578 (238)

α‐sarcin and RNase T1 based immunoconjugates: the role of intracellular trafficking in cytotoxic efficiency

open access: yesThe FEBS Journal, 2015
Toxins have been thoroughly studied for their use as therapeutic agents in search of an improvement in toxic efficiency together with a minimization of their undesired side effects.
J. Tomé-Amat   +4 more
semanticscholar   +2 more sources

Porcine sialoadhesin (CD169/Siglec-1) is an endocytic receptor that allows targeted delivery of toxins and antigens to macrophages. [PDF]

open access: yesPLoS ONE, 2011
Sialoadhesin is exclusively expressed on specific subpopulations of macrophages. Since sialoadhesin-positive macrophages are involved in inflammatory autoimmune diseases, such as multiple sclerosis, and potentially in the generation of immune responses ...
Peter L Delputte   +9 more
doaj   +1 more source

Management of HER2-Low Metastatic Breast Cancer: A Comprehensive Statement by an Expert Group from the Middle East and Africa Region [PDF]

open access: yesMiddle East Journal of Cancer
Approximately 50 to 67% of breast cancers (BCs), traditionally categorized as human epidermal growth factor receptor 2 (HER2)-negative, but demonstrating low HER2 expression, are now being defined as a new HER2-low subset or HER2-low category of BC.
Shaheenah Dawood   +9 more
doaj   +1 more source

Antibody-Drug Conjugates: Functional Principles and Applications in Oncology and Beyond

open access: yesVaccines, 2021
In the era of precision medicine, antibody-based therapeutics are rapidly enriched with emerging advances and new proof-of-concept formats. In this context, antibody-drug conjugates (ADCs) have evolved to merge the high selectivity and specificity of ...
Charalampos Theocharopoulos   +4 more
doaj   +1 more source

Antibody-drug conjugates in treating older patients suffering from cancer: what is the real value?

open access: yesHuman Vaccines & Immunotherapeutics, 2021
Immunotherapeutic drugs and target therapies have represented an epochal change in treating cancer patients. They represent an attractive option in oncologists’ armamentarium, particularly if we consider the optimal balance between efficacy and toxicity.
Gianluca Perego   +3 more
doaj   +1 more source

Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases

open access: yesBiosensors, 2021
A magnetic beads (MB)-involved amperometric immunosensor for the determination of ST2, a member of the IL1 receptor family, is reported in this work.
Rebeca M. Torrente-Rodríguez   +8 more
doaj   +1 more source

Analytical approaches for assessing immunoconjugates integrity and characterization prior to radiolabeling [PDF]

open access: yes, 2023
Immunoconjugates, which have highly specific targeting towards certain antigens, are molecules that are built from three parts: an antibody, a therapeutic payload, and a linker between them.
Janevik-Ivanovska, Emilija   +2 more
core  

DOTA-functionalized polylysine: a high number of DOTA chelates positively influences the biodistribution of enzymatic conjugated anti-tumor antibody chCE7agl. [PDF]

open access: yesPLoS ONE, 2013
Site-specific enzymatic reactions with microbial transglutaminase (mTGase) lead to a homogenous species of immunoconjugates with a defined ligand/antibody ratio.
Jürgen Grünberg   +6 more
doaj   +1 more source

Evaluation of immunoconjugates of non-radioactive lutetium- and yttrium-rituximab – a vibrational spectroscopy study

open access: yesMacedonian Journal of Chemistry and Chemical Engineering, 2015
Fourier Transform Infrared (FT-IR) and Raman spectroscopy were used to study the molecular structure of the recombinant monoclonal antibody and anti-CD20-conjugates which are intended to be used as anti-cancer therapeutic agents.
Darinka Gjorgieva Ackova   +5 more
doaj   +1 more source

Humanization, Radiolabeling and Biodistribution Studies of an IgG1-Type Antibody Targeting Uncomplexed PSA for Theranostic Applications

open access: yesPharmaceuticals, 2021
Metastatic castration-resistant prostate cancer is today incurable. Conventional imaging methods have limited detection, affecting their ability to give an accurate outcome prognosis, and current therapies for metastatic prostate cancer are insufficient.
Joanna Strand   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy